Compensatory regulation of RIalpha protein levels in protein kinase A mutant mice. 1997

P S Amieux, and D E Cummings, and K Motamed, and E P Brandon, and L A Wailes, and K Le, and R L Idzerda, and G S McKnight
Department of Pharmacology, University of Washington, Seattle, Washington 98195-7750, USA.

The cAMP-dependent protein kinase holoenzyme is assembled from regulatory (R) and catalytic (C) subunits that are expressed in tissue-specific patterns. Despite the dispersion of the R and C subunit genes to different chromosomal loci, mechanisms exist that coordinately regulate the intracellular levels of R and C protein such that cAMP-dependent regulation is preserved. We have created null mutations in the RIbeta and RIIbeta regulatory subunit genes in mice, and find that both result in an increase in the level of RIalpha protein in tissues that normally express the beta isoforms. Examination of RIalpha mRNA levels and the rates of RIalpha protein synthesis in wild type and RIIbeta mutant mice reveals that the mechanism of this biochemical compensation by RIalpha does not involve transcriptional or translational control. These in vivo findings are consistent with observations made in cell culture, where we demonstrate that the overexpression of Calpha in NIH 3T3 cells results in increased RIalpha protein without increases in the rate of RIalpha synthesis or the level of RIalpha mRNA. Pulse-chase experiments reveal a 4-5-fold increase in the half-life of RIalpha protein as it becomes incorporated into the holoenzyme. Compensation by RIalpha stabilization may represent an important biological mechanism that safeguards cells from unregulated catalytic subunit activity.

UI MeSH Term Description Entries
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations
D016475 3T3 Cells Cell lines whose original growing procedure consisted being transferred (T) every 3 days and plated at 300,000 cells per plate (J Cell Biol 17:299-313, 1963). Lines have been developed using several different strains of mice. Tissues are usually fibroblasts derived from mouse embryos but other types and sources have been developed as well. The 3T3 lines are valuable in vitro host systems for oncogenic virus transformation studies, since 3T3 cells possess a high sensitivity to CONTACT INHIBITION. 3T3 Cell,Cell, 3T3,Cells, 3T3
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D054756 Cyclic AMP-Dependent Protein Kinase RIalpha Subunit A type I cAMP-dependent protein kinase regulatory subunit that plays a role in confering CYCLIC AMP activation of protein kinase activity. It has a lower affinity for cAMP than the CYCLIC-AMP-DEPENDENT PROTEIN KINASE RIBETA SUBUNIT. Protein Kinase A, RIalpha Subunit,Cyclic-AMP-Dependent Protein Kinase RIalpha Subunit,RI alpha, cAMP Protein Kinase,RIalpha, PKA,RIalpha, Protein Kinase A,RIalpha, cAMP Protein Kinase,Regulatory Subunit RIalpha, Cyclic-AMP-Dependent Protein Kinase,Cyclic AMP Dependent Protein Kinase RIalpha Subunit,PKA RIalpha,Regulatory Subunit RIalpha, Cyclic AMP Dependent Protein Kinase
D017868 Cyclic AMP-Dependent Protein Kinases A group of enzymes that are dependent on CYCLIC AMP and catalyze the phosphorylation of SERINE or THREONINE residues on proteins. Included under this category are two cyclic-AMP-dependent protein kinase subtypes, each of which is defined by its subunit composition. Adenosine Cyclic Monophosphate-Dependent Protein Kinases,Protein Kinase A,cAMP Protein Kinase,cAMP-Dependent Protein Kinases,Cyclic AMP-Dependent Protein Kinase,cAMP-Dependent Protein Kinase,Adenosine Cyclic Monophosphate Dependent Protein Kinases,Cyclic AMP Dependent Protein Kinase,Cyclic AMP Dependent Protein Kinases,Protein Kinase, cAMP,Protein Kinase, cAMP-Dependent,Protein Kinases, cAMP-Dependent,cAMP Dependent Protein Kinase,cAMP Dependent Protein Kinases

Related Publications

P S Amieux, and D E Cummings, and K Motamed, and E P Brandon, and L A Wailes, and K Le, and R L Idzerda, and G S McKnight
September 2000, Clinical cancer research : an official journal of the American Association for Cancer Research,
P S Amieux, and D E Cummings, and K Motamed, and E P Brandon, and L A Wailes, and K Le, and R L Idzerda, and G S McKnight
November 2005, Annals of the New York Academy of Sciences,
P S Amieux, and D E Cummings, and K Motamed, and E P Brandon, and L A Wailes, and K Le, and R L Idzerda, and G S McKnight
June 2010, Protein science : a publication of the Protein Society,
P S Amieux, and D E Cummings, and K Motamed, and E P Brandon, and L A Wailes, and K Le, and R L Idzerda, and G S McKnight
May 2003, The Journal of biological chemistry,
P S Amieux, and D E Cummings, and K Motamed, and E P Brandon, and L A Wailes, and K Le, and R L Idzerda, and G S McKnight
March 1998, FEBS letters,
P S Amieux, and D E Cummings, and K Motamed, and E P Brandon, and L A Wailes, and K Le, and R L Idzerda, and G S McKnight
August 2013, Arteriosclerosis, thrombosis, and vascular biology,
P S Amieux, and D E Cummings, and K Motamed, and E P Brandon, and L A Wailes, and K Le, and R L Idzerda, and G S McKnight
February 2002, Clinical cancer research : an official journal of the American Association for Cancer Research,
P S Amieux, and D E Cummings, and K Motamed, and E P Brandon, and L A Wailes, and K Le, and R L Idzerda, and G S McKnight
October 2007, Proteins,
P S Amieux, and D E Cummings, and K Motamed, and E P Brandon, and L A Wailes, and K Le, and R L Idzerda, and G S McKnight
April 2001, Cancer letters,
P S Amieux, and D E Cummings, and K Motamed, and E P Brandon, and L A Wailes, and K Le, and R L Idzerda, and G S McKnight
January 2018, Cell cycle (Georgetown, Tex.),
Copied contents to your clipboard!